Evidence map›Paper›PMID 33335741›Full record

ArticleCanadian journal of kidney health and disease2020

Technique Survival and Determinants of Technique Failure in In-Center Nocturnal Hemodialysis: A Retrospective Observational Study.

Michael E Schachter, Marc J Saunders, Ayub Akbari, Julia M Caryk, Ann Bugeja, Edward G Clark, Karthik K Tennankore, Dan J Martinusen

Open access · goldAbstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Michael E SchachterDivision of Nephrology, Vancouver Island Health Authority, Victoria, BC, Canada.
Marc J SaundersMaster of Biomedical Technology Program, University of Calgary, AB, Canada.ORCID https://orcid.org/0000-0001-8883-9983
Ayub AkbariDivision of Nephrology, The Ottawa Hospital and University of Ottawa, ON, Canada.
Julia M CarykDivision of Nephrology, Vancouver Island Health Authority, Victoria, BC, Canada.
Ann BugejaDivision of Nephrology, The Ottawa Hospital and University of Ottawa, ON, Canada.ORCID https://orcid.org/0000-0002-4106-0451
Edward G ClarkDivision of Nephrology, The Ottawa Hospital and University of Ottawa, ON, Canada.ORCID https://orcid.org/0000-0002-6767-1197
Karthik K TennankoreDivision of Nephrology, Dalhousie University, Halifax, NS, Canada.ORCID https://orcid.org/0000-0002-7919-6709
Dan J MartinusenDivision of Nephrology, Vancouver Island Health Authority, Victoria, BC, Canada.
Island Health · CAUniversity of Ottawa · CADalhousie University · CAUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong-duration (7-8 hours) hemodialysis provides benefits compared with conventional thrice-weekly, 4-hour sessions. Nurse-administered, in-center nocturnal hemodialysis (INHD) may expand the population to whom an intensive dialysis schedule can be offered.

objectiveThe primary objective of this study was to determine predictors of INHD technique failure, disruptions, and technique survival.

designThis study used retrospective chart and database review methodology.

settingThis study was conducted at a single Canadian INHD program operating in Victoria, British Columbia, within a tertiary care hospital. Our program serves a catchment population of approximately 450 000 people. PATIENTS/SAMPLE/

participantsForty-three consecutive incident INHD patients took part in the INHD program of whom 42 provided informed consent to participate in this study.

methodsWe conducted a retrospective observational study including incident INHD patients from 2015 to 2017. The primary outcome was technique failure ≤6 months (TF ≤6). Secondary outcomes included technique survival and reasons for/predictors of INHD discontinuation or temporary disruption. Predictors of each outcome included demographics, comorbidities, and Clinical Frailty Scale (CFS) scoring.

resultsAmong 42 patients, mean (SD) age, dialysis vintage, CFS score, and follow-up were 63 (16) years, 46 (55) months, 4 (1), and 11 (9) months, respectively. 52% were aged ≥65 years. TF ≤6 occurred in 12 (29%) patients. One-year technique survival censored for transplants and home dialysis transitions was 60%. Discontinuation related to insomnia (32%), medical status change (27%), and vascular access (23%). In unadjusted Cox survival analysis, 1-point increases in CFS score associated with a higher risk of technique failure (hazard ratio: 2.04, 95% confidence interval [CI]: 1.26-3.31). In an adjusted analysis, higher frailty severity also associated with temporary INHD disruptions (incidence rate ratio: 2.64, 95% CI: 1.55-4.50, comparing CFS of ≥4 to 1-3). LIMITATIONS: The retrospective, observational design of this study resulted in limited ability to control for confounding factors. In addition, the relatively small number of events observed owing to a small sample size diminished statistical power to inform study conclusions. Use of a single physician to determine the clinical frailty score is another limitation. Finally, the use of a single center for this study limits generalizability to other programs and clinic settings.

conclusionsINHD is a sustainable modality, even among older patients. Higher frailty associates with INHD technique failure and greater missed treatments. Inclusion of a CFS threshold of ≤4 into INHD inclusion criteria may help to identify individuals most likely to realize the long-term benefits of INHD.

trial registrationDue to the retrospective and observational design of this study, trial registration was not necessary.

Indexed as

chronic hemodialysischronic renal insufficiencyClinical Frailty ScaledialysisESRD

Identifiers

PMID33335741
PMCPMC7724416
OpenAlexW3111117811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.